GlassScriptPhysician profile
Mariah Butcher
NPI 1982339958
$2,627.79
in general payments reported to CMS, 2019-2025
17 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $570 · 2023: $995 · 2024: $955 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,858 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,857.67 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $715.62 | 2022-2025 | |
| Janssen Biotech, INC. | $324.89 | 2023-2024 | Tremfya |
| Incyte Corporation | $282.42 | 2023-2024 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $240.79 | 2022-2024 | Sotyktu |
| Pfizer INC. | $224.95 | 2022-2024 | |
| Genzyme Corporation | $162.25 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $146.32 | 2022-2024 | Dupixent |
| Lilly USA, LLC | $123.51 | 2023-2024 | Taltz, Olumiant |
| Amgen INC. | $107.43 | 2023-2024 | Otezla |
| Leo Pharma INC. | $69.78 | 2022-2024 | Adbry |
| Almirall LLC | $46.07 | 2022-2023 | Seysara |
| Ucb, INC. | $39.63 | 2022-2024 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $37.60 | 2023 | |
| Dermavant Sciences, INC. | $37.33 | 2023-2024 | Vtama |
| Mallinckrodt Hospital Products INC. | $32.01 | 2024 | Acthar |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $22.52 | 2023 | |
| Galderma Laboratories, L.P. | $14.67 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariah Butcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.